c-ANCA positivity in a Belgian patient with pulmonary paracoccidioidomycosis

European Respiratory Journal

Volumn 10, Issue 10, 1997, Pages 2419-2422

  Stappaerts, I ^a   Bogers, J ^a   Ebo, D ^a   Vanden Broecke, E ^b   Stevens, W J ^a   Vermeire, P ^a  

^a ANTWERP UNIVERSITY HOSPITAL   (Belgium)

^b St Jozef General Hospital   (Belgium)

Author keywords

Antineutrophil cytoplasmic antibodies; Interstitial lung disease; Paracoccidioidomycosis

Indexed keywords

ITRACONAZOLE; NEUTROPHIL CYTOPLASMIC ANTIBODY;

ADULT; ARTICLE; BRONCHUS BIOPSY; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; HUMAN; HUMAN TISSUE; LUNG BIOPSY; MALE; PRIORITY JOURNAL; SERODIAGNOSIS; SOUTH AMERICAN BLASTOMYCOSIS; WEGENER GRANULOMATOSIS;

AGED; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; ANTIFUNGAL AGENTS; DISEASE-FREE SURVIVAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; ITRACONAZOLE; LUNG DISEASES, FUNGAL; MALE; PARACOCCIDIOIDOMYCOSIS; RESPIRATORY FUNCTION TESTS; THORACOSCOPES; TOMOGRAPHY, X-RAY COMPUTED; WEGENER GRANULOMATOSIS;

EID: 0030670108     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.97.10102419     Document Type: Article

References (23)

1. Taborda A, Arechavala AI. Paracoccidioidomycosis. In: Sarosi GA, Davies SF, eds. Fungal Diseases of the Lung. New York, Raven Press, 1993; pp. 85-94.
2. Rios-Fabra A, Restrepo Moreno A, Isturiz RE. Fungal infection in Latin American countries. Infect Dis Clin North Am 1994; 8: 141-145.
3. Colombo AL, Faiçal S, Kater CE. Systematic evaluation of the adrenocortical function in patients with paracoccidioidomycosis. Mycopathologia 1994; 127: 89-93.
4. Brummer E, Castañeda E, Restrepo A. Paracoccidioidomycosis: an update. Clin Microbiol Rev 1993; 62: 89-117.
5. Iwama de Mattos MCF, Mendes RP, Marcondes-Machado J, et al. Sputum cytology in the diagnosis of pulmonary paracoccidioidomycosis. Mycopathologia 1991; 114: 187-191.
6. Del Negro GMB, Garcia NM, Rodrigues EG, et al. The sensitivity, specificity and efficiency values of some serological tests used in the diagnosis of paracoccidioidomycosis. Rev Inst Med Trop São Paulo 1991; 33: 277-280.
7. Naranjo MS, Trujillo M, Munera MI, Restrepo P, Gomez I, Restrepo A. Treatment of paracoccidioidomycosis with itraconazole. J Med Vet Mycol 1990; 28: 67-76.
8. Restrepo A. Treatment of tropical mycosis. J Am Acad Dermatol 1994; 31: S91-S93.
9. Gross WL, Schmitt WH, Csernock E. Antineutrophil cytoplasmic autoantibody-associated diseases: a rheumatologist's perspective. Am J Kidney Dis 1991; 18: 175-179.
10. Gross WL, Schmitt WH, Csernock E. ANCA and associated diseases: immunodiagnostic and pathogenetic aspects. Clin Exp Immunol 1993; 91: 1-12.
11. McHugh NJ, James IE, Plant GT. Anticardiolipin and antineutrophil antibodies in giant cell arthritis. J Rheumatol 1990; 17: 916-922.
12. Kerr GS, Fleisher TA, Hallahan CW, Leavitt RY, Fauci AS, Hoffman GS. Limited prognostic value of changes in antineutrophil cytoplasmic antibody titer in patients with Wegener's granulomatosis. Arthritis Rheum 1993; 36: 365-371.
13. Savige J A, Gallicchio MC, Stockman A, et al. Antineutrophil cytoplasmic antibodies in rheumatoid arthritis. Clin Exp Immunol 1991; 86: 92-98.
14. Schmitt WH, Csernock E, Gross WL. ANCA and infection. Lancet 1991; 337: 1416-1417.
15. Murphy EA, McVie A, Galbraith I, Capell HA. Antineutrophil cytoplasmic antibody titres in patients with recent infection (letter). Br J Rheumatol 1993; 32: 84.
16. Klaassen RJL, Goldschmeding R, Dolman KM, et al. Antineutrophil cytoplasmic autoantibodies in patients with symptomatic HIV infection. Clin Exp Immunol 1992; 87: 24-30.
17. De Clerck LS, Van Offel JF, Smolders WA, et al. Pitfalls with antineutrophil cytoplasmic antibodies (ANCA). Clin Rheumatol 1989; 8: 512-516.
18. Adebajo AO, Charles P, Hazleman BL, Maini RN. Antineutrophil cytoplasmic antibody titres in patients with recent infection. Br J Rheumatol 1993; 32: 941-942.
19. Pudifin D, Duursma J, Garhiram V, Jackson T. Invasive amoebiasis is associated with the development of antineutrophil cytoplasmic antibody. Clin Exp Immunol 1994; 97: 48-51.
20. Davenport A, Lock RJ, Wallington TB. Clinical relevance of testing for antineutrophil cytoplasm antibodies (ANCA) with a standard indirect immunofluorescence ANCA test in patients with upper or lower respiratory tract symptoms. Thorax 1994; 49: 213-217.
21. Yang JJ, Tuttle R, Falk RJ, Jennett JC. Frequencies of antibactericidal permeability-increasing protein (BPI) and anti-azurodin in patients with renal disease. Clin Exp Immunol 1996; 105: 125-131.
22. Csernok E, Schmitt WH, Ernst M, Bainton D, Gross WL. Membrane surface proteinase 3 expression and intracytoplasmic immunoglobulin on neutrophil from patients with ANCA-associated vasculitides. Adv Exp Med Biol 1993; 336: 45-50.
23. Henshaw TJ, Malone CC, Gabay JE, Williams RC. Elevations of neutrophil proteinase-3 in serum of patients with Wegener's granulomatosis and polyarteritis nodosa. Arthritis Rheum 1994; 37: 104-107.